These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3180544)

  • 1. HLA antigens and clinical manifestations in Crohn's disease.
    Modena V; Amoroso A; Frattasio C; Pera A; Costantini P; Maiocco I; Ponti V; Di Vittorio CC; Verme G; Curtoni ES
    Clin Exp Rheumatol; 1988; 6(3):221-5. PubMed ID: 3180544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histocompatibility antigens and other markers in ankylosing spondylitis and inflammatory bowel diseases.
    van dan Berg-Loonen PM; Dekker-Saeys AJ; Meuwissen SG; Nijenhuis LE
    J Rheumatol Suppl; 1977; 3():57-9. PubMed ID: 266599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Rheumatic manifestations in 80 cases of Crohn's disease].
    Deshayes P; Geffroy Y; Houdent C; Hetcketsweiler P; Colin R; Cavelier B; Monconduit M; Ropartz C
    Rev Rhum Mal Osteoartic; 1976 May; 43(5):345-55. PubMed ID: 1084009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The association between ankylosing spondylitis, Crohn's disease and HLA-B27. A study of seven patients].
    Mulero J; Abreu L; Chantar C; Cruz J; Barrios C; Noguera E
    Med Clin (Barc); 1982 Jun; 79(1):27-30. PubMed ID: 6981742
    [No Abstract]   [Full Text] [Related]  

  • 5. Histocompatibility antigens and other genetic markers in ankylosing spondylitis and inflammatory bowel diseases.
    van den Berg-Loonen EM; Dekker-Saeys BJ; Meuwissen SG; Nijenhuis LE; Engelfriet CP
    J Immunogenet; 1977 Jun; 4(3):167-75. PubMed ID: 901632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histocompatibility antigens in inflammatory bowel disease. Their clinical significance and their association with arthropathy with special reference to HLA-B27 (W27).
    Mallas EG; Mackintosh P; Asquith P; Cooke WT
    Gut; 1976 Nov; 17(11):906-10. PubMed ID: 1001980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic survey of the HLA B27 prevalence in inflammatory rheumatic diseases.
    Dequeker J; Decock T; Walravens M; Van de Putte I
    J Rheumatol; 1978; 5(4):452-9. PubMed ID: 739494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA antigens in ankylosing spondylitis associated with Crohn's disease. Increased frequency of the HLA phenotype B27,B44.
    Purrmann J; Zeidler H; Bertrams J; Juli E; Cleveland S; Berges W; Gemsa R; Specker C; Reis HE
    J Rheumatol; 1988 Nov; 15(11):1658-61. PubMed ID: 3266250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interdependence of ankylosing spondylitis and Crohn's disease].
    Lysy Y; Branski D
    Harefuah; 1986 Jan; 110(1):26-7. PubMed ID: 3485554
    [No Abstract]   [Full Text] [Related]  

  • 10. Gram-negative bacteria, HLA-B27 and inflammatory bowel disease.
    Pease PE; Lane MR; Chahal H; Tallack JE; Allan RN
    Br J Rheumatol; 1988; 27 Suppl 2():29-31. PubMed ID: 3261188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ankylosing spondylitis and inflammatory bowel disease. III. Clinical characteristics and results of histocompatibility typing (HLA B27) in 50 patients with both ankylosing spondylitis and inflammatory bowel disease.
    Dekker-Saeys BJ; Meuwissen SG; Van Den Berg-Loonen EM; De Haas WH; Meijers KA; Tytgat GN
    Ann Rheum Dis; 1978 Feb; 37(1):36-41. PubMed ID: 629602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA B27 in regional enteritis with and without ankylosing spondylitis or sacroiliitis.
    Huaux JP; Fiasse R; De Bruyere M; Nagant de Deuxchaisnes C
    J Rheumatol Suppl; 1977; 3():60-3. PubMed ID: 266600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features of inflammatory joint and spine manifestations in Crohn's disease.
    Münch H; Purrmann J; Reis HE; Bertrams J; Zeidler H; Stolze T; Miller B; Korsten S; Cremers J; Strohmeyer G
    Hepatogastroenterology; 1986 Jun; 33(3):123-7. PubMed ID: 3488946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA B27 in the population of northern Sweden.
    Bjelle A; Cedergren B; Dahlqvist SR
    Scand J Rheumatol; 1982; 11(1):23-6. PubMed ID: 6977838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological studies in Crohn's disease. I. Association with HLA systems in the Japanese.
    Fujita K; Naito S; Okabe N; Yao T
    J Clin Lab Immunol; 1984 Jun; 14(2):99-102. PubMed ID: 6611420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality in pacemaker-treated patients. A follow-up study of the impact of HLA B27 and associated rheumatic disorders.
    Bergfeldt L; Allebeck P; Edhag O
    Acta Med Scand; 1987; 222(4):293-9. PubMed ID: 3501228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexisting rheumatoid arthritis and ankylosing spondylitis.
    Fallet GH; Barnes CG; Berry H; Mowat AG; Roux H; Villiaumey J
    J Rheumatol; 1987 Dec; 14(6):1135-8. PubMed ID: 3437421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic significance of the occurrence of tissue antigen HLA-B27 in various rheumatic diseases].
    Kuthan F; Streda A; Parma R; Krepelková M; Hill Z; Valnícková Z
    Vnitr Lek; 1979 Jun; 25(6):578-3. PubMed ID: 313621
    [No Abstract]   [Full Text] [Related]  

  • 19. [Seronegative spondylo-arthropathies and HLA-B27].
    Kaludi M
    Union Med Can; 1984 Jun; 113(6):455-9, 521. PubMed ID: 6333098
    [No Abstract]   [Full Text] [Related]  

  • 20. [HLA-B27 antigen in ankylosing spondylitis and other forms of rheumatism (author's transl)].
    Macera C; Losada M; Melendez M; Fuentes C; Mauritz AM
    Rev Med Chil; 1977 Feb; 105(2):90-2. PubMed ID: 877468
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.